Molina Healthcare Inc (MOH) (Q3 2026) Earnings Call Highlights: Reaffirmed Guidance
Molina Healthcare (MOH) reported Q3 2026 adjusted pre-tax margin of 0.6% and reaffirmed guidance. Medicaid cost trend rose to 5.5%, and new contracts in Georgia/Texas were delayed. Marketplace and Medicare MAPD segments are expected to lose $0.75 and $1 per share, respectively, in 2026. CEO Joe Zubretsky and CFO Mark Keim discussed Medicaid MLR improvements, Florida CMS contract, and enrollment declines.
How this was made

The 30-second read
Why it matters
The disclosed low margins and delayed contracts suggest near‑term earnings pressure, but management cites rate updates and cost improvements for Q4.
Market read
Guidance shortfall may trigger a sell‑off in MOH and influence sentiment toward similar health‑care insurers.
What to watch
Potential upside from cost‑control measures and G&A improvements mentioned for Q4 could mitigate margin weakness.
Background
Molina Healthcare provided its Q3 2026 earnings call, reaffirming guidance and outlining operational challenges.
Ticker impact
Earnings call disclosed low adjusted pre‑tax margin of 0.6% in Q3 2026, delayed $1.3 B Medicaid contracts and projected losses in Marketplace and Medicare MAPD segments.
downward pressure as investors price in lower margins and contract delays
Margins are near break‑even and significant revenue is pushed to 2027‑28; guidance loss per share signals earnings shortfall.
Market effects
Highlights pressure on Medicaid‑focused insurers and may affect peer health‑maintenance organization stocks.
Potential downside for U.S. health‑care sector indices.
Limited to U.S. health‑care market; no broader macro impact.
Counterpoint
If Medicaid enrollment stabilizes faster than expected, the delayed contracts could boost future earnings, offering a buying opportunity at depressed prices.
Key entities
- CompanyMolina Healthcare Inc.
U.S. Medicaid and Medicare insurer.
- ExecutiveJoe Zubretsky
CEO of Molina Healthcare.
- ExecutiveMark Keim
CFO of Molina Healthcare.


